Peptidream Stock Net Income
| PPTDF Stock | USD 10.42 0.00 0.00% |
As of the 10th of February, PeptiDream holds the insignificant Risk Adjusted Performance, coefficient of variation of (6,726), and Variance of 10.16. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PeptiDream, as well as the relationship between them. Please check PeptiDream market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if PeptiDream is priced some-what accurately, providing market reflects its current price of 10.42 per share. Given that PeptiDream has information ratio of (0.05), we recommend you to check out PeptiDream's recent market performance to make sure the company can sustain itself at a future point.
PeptiDream's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PeptiDream's valuation are provided below:PeptiDream does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. PeptiDream |
PeptiDream 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PeptiDream's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PeptiDream.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in PeptiDream on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding PeptiDream or generate 0.0% return on investment in PeptiDream over 90 days. PeptiDream is related to or competes with Mesoblast, Oxford Nanopore, Pharma Mar, Neuren Pharmaceuticals, CStone Pharmaceuticals, Genus Plc, and SanBio Company. PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small mo... More
PeptiDream Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PeptiDream's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PeptiDream upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 20.35 | |||
| Value At Risk | (6.15) | |||
| Potential Upside | 5.0 |
PeptiDream Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PeptiDream's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PeptiDream's standard deviation. In reality, there are many statistical measures that can use PeptiDream historical prices to predict the future PeptiDream's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PeptiDream's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PeptiDream February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 1.28 | |||
| Coefficient Of Variation | (6,726) | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.16 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 20.35 | |||
| Value At Risk | (6.15) | |||
| Potential Upside | 5.0 | |||
| Skewness | 1.88 | |||
| Kurtosis | 8.5 |
PeptiDream Backtested Returns
At this point, PeptiDream is somewhat reliable. PeptiDream maintains Sharpe Ratio (i.e., Efficiency) of 0.058, which implies the firm had a 0.058 % return per unit of risk over the last 3 months. We have found eighteen technical indicators for PeptiDream, which you can use to evaluate the volatility of the company. Please check PeptiDream's Coefficient Of Variation of (6,726), insignificant risk adjusted performance, and Variance of 10.16 to confirm if the risk estimate we provide is consistent with the expected return of 0.18%. PeptiDream has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.82, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PeptiDream's returns are expected to increase less than the market. However, during the bear market, the loss of holding PeptiDream is expected to be smaller as well. PeptiDream right now holds a risk of 3.12%. Please check PeptiDream jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if PeptiDream will be following its historical price patterns.
Auto-correlation | -0.89 |
Excellent reverse predictability
PeptiDream has excellent reverse predictability. Overlapping area represents the amount of predictability between PeptiDream time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PeptiDream price movement. The serial correlation of -0.89 indicates that approximately 89.0% of current PeptiDream price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.89 | |
| Spearman Rank Test | -0.89 | |
| Residual Average | 0.0 | |
| Price Variance | 0.5 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, PeptiDream reported net income of 3.61 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net income for all United States stocks is significantly lower than that of the firm.
PeptiDream Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PeptiDream's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PeptiDream could also be used in its relative valuation, which is a method of valuing PeptiDream by comparing valuation metrics of similar companies.PeptiDream is currently under evaluation in net income category among its peers.
PeptiDream Fundamentals
| Return On Equity | 0.0023 | |||
| Return On Asset | -0.0067 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 1.74 B | |||
| Shares Outstanding | 129.83 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 44.96 % | |||
| Price To Earning | 38.54 X | |||
| Price To Book | 9.39 X | |||
| Price To Sales | 0.12 X | |||
| Revenue | 9.37 B | |||
| Gross Profit | 7.01 B | |||
| EBITDA | 5.05 B | |||
| Net Income | 3.61 B | |||
| Cash And Equivalents | 6.79 B | |||
| Cash Per Share | 52.31 X | |||
| Total Debt | 21.64 B | |||
| Debt To Equity | 0.87 % | |||
| Current Ratio | 2.43 X | |||
| Book Value Per Share | 188.49 X | |||
| Cash Flow From Operations | 6.65 B | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 670 | |||
| Beta | 0.64 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 26.62 B | |||
| Net Asset | 26.62 B |
About PeptiDream Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PeptiDream's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PeptiDream using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PeptiDream based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in PeptiDream Pink Sheet
PeptiDream financial ratios help investors to determine whether PeptiDream Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PeptiDream with respect to the benefits of owning PeptiDream security.